T Cell-Produced Transforming Growth Factor-β1 Controls T Cell Tolerance and Regulates Th1- and Th17-Cell Differentiation
Top Cited Papers
Open Access
- 1 May 2007
- Vol. 26 (5), 579-591
- https://doi.org/10.1016/j.immuni.2007.03.014
Abstract
No abstract availableKeywords
Funding Information
- American Diabetes Association (RO1DK51665)
- Arthritis Foundation
- National Institutes of Health
This publication has 50 references indexed in Scilit:
- Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune diseaseThe Journal of Experimental Medicine, 2006
- Interleukin-23 drives innate and T cell–mediated intestinal inflammationThe Journal of Experimental Medicine, 2006
- IL-23 plays a key role inHelicobacter hepaticus–induced T cell–dependent colitisThe Journal of Experimental Medicine, 2006
- Transforming Growth Factor-β Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent MechanismsImmunity, 2006
- IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6Journal of Clinical Investigation, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Effector and memory CD8+ T cell fate coupled by T-bet and eomesoderminNature Immunology, 2005
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Conditional gene targeting.Journal of Clinical Investigation, 1996
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992